MREO - Mereo BioPharma's (MREO) CEO Denise Scots-Knight on 2019 Interim Financial Results and Corporate Update Conference Call
Mereo BioPharma Group plc (MREO)
2019 Interim Financial Results and Corporate Update Conference Call
September 17, 2019 8:00 AM ET
Company Participants
Richard Jones – Chief Financial Officer
Denise Scots-Knight – Chief Executive Officer
Conference Call Participants
Brian White – Cantor Fitzgerald
Zoe Karamanoli – RBC Capital Markets
Mick Cooper – Trinity Delta
Presentation
Operator
Good morning ladies and gentlemen. Thank you for standing by and welcome to the Mereo BioPharma 2019 Interim Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions